Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

Stem Cells Market And Applications. 2009-2015

2835.57

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,835.57

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

7 August 2010

Number of Pages

468

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

Axis Research Mind

File Format

-

Report: Global stem cells market forecast to reach US$63.8 billion by 2015

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. The major therapeutic use in stem cells market is classified into oncology, cardiology, and bone & cartilage. Among the therapeutic areas, neurology is forecasts to exert highest support to the stem cells market growth with a CAGR of 24.4% during 2010-2015. Hematology and diabetes are expected to lead the stem cell market during 2010-2015.

The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.

Improving health consciousness in Europe will likely maintain the stem cell market of the European Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.

Report scope

The ‘Stem Cells Market and Applications, 2009-2015' reviews the latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

Latest Market Trends
Region-wise Demand Factor
Key Growth Areas
Market Sizes
Key Competitors Edge
Investment Strategies

The report delivers a microscopic overview of major product segments and therapeutic areas of stem cells market, regionally. The stem cells product segments includes adult stem cells, cord blood stem cells, embryonic stem cells and others while stem cells therapeutic areas includes bone & cartilage, cardiac, skin, diabetes, blood disorders, neuro, cancer, digestive system, drug development, eyes, injuries, reproductive system and others.

The report focuses on the major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the near future are profiled. The report consists of 313 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific); Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the Stem Cells industry.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,835.57

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings